EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Impact of Dronedarone on Early Recurrence After Catheter Ablation in Patients With Nonparoxysmal Atrial Fibrillation

Xianglin Long iD, Han Lv, Jingliang Zhang, Xiaoyan Wang, Shan Tu, Xu Deng, Lixiong Zeng, Wenzhi Luo, Fei Ye, Zhihui Zhang iD

Cardiovascular Therapeutics · 2025

DOI: 10.1155/cdr/2585953 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cardiovascular Therapeutics, 2025. Verfasst von Xianglin Long und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Dronedarone, Atrial Fibrillation, Anti-Arrhythmia Agents, Catheter Ablation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study is aimed at comparing the efficacy and safety of dronedarone, amiodarone, and propafenone in preventing early recurrence of atrial arrhythmias during the blanking period following catheter ablation in patients with nonparoxysmal atrial fibrillation.

Methods

We retrospectively analyzed 408 patients with nonparoxysmal atrial fibrillation who underwent their first catheter ablation. Patients were divided into three groups based on the postoperative antiarrhythmic drug prescribed: dronedarone, amiodarone, or propafenone. A propensity score matching (PSM) analysis was performed as the primary analysis to compare early recurrence rates and drug‐related adverse events. An inverse probability of treatment weighting (IPW) analysis was conducted as a sensitivity analysis.

Results

Of the 408 patients, 65 (15.9%) experienced early recurrence. The early recurrence rate was significantly lower in the dronedarone group (9.2%) compared to propafenone (27.2%), but not significantly different from amiodarone (14.0%). The dronedarone group showed a lower recurrence rate of atrial flutter compared to both the propafenone and amiodarone groups ( p < 0.05). After PSM, the recurrence rate of atrial flutter remained significantly lower in the dronedarone group compared to propafenone and amiodarone. Regarding drug‐related adverse events, 73 patients (17.9%) experienced adverse reactions, with the amiodarone group showing a significantly higher incidence (24.2%) compared to the propafenone (13.6%) and dronedarone (11.8%) groups.

Conclusion

In this retrospective study of patients with nonparoxysmal atrial fibrillation after catheter ablation, dronedarone and amiodarone showed a trend toward better efficacy than propafenone in preventing overall early recurrence. Dronedarone demonstrated a specific advantage in preventing early recurrence of atrial flutter.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DronedaroneAtrial FibrillationAnti-Arrhythmia AgentsCatheter AblationAtrial FlutterAmiodaroneHumansRetrospective StudiesMaleFemaleMiddle AgedRecurrenceTreatment OutcomeAgedTime FactorsPropafenoneRisk FactorsSecondary PreventionPropensity Score

Stichwörter der Autor:innen

dronedaroneearly recurrencenonparoxysmal atrial fibrillationradiofrequency ablation

Substanzen

DronedaroneAnti-Arrhythmia AgentsPropafenoneAmiodarone

Autor:innen und Institutionen

  • Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.

ORCID-Profile: Xianglin Long, Zhihui Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Long, X., Lv, H., Zhang, J., Wang, X., Tu, S., Deng, X., Zeng, L., Luo, W., Ye, F., & Zhang, Z. (2025). Impact of Dronedarone on Early Recurrence After Catheter Ablation in Patients With Nonparoxysmal Atrial Fibrillation. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/2585953

Vancouver

Long X, Lv H, Zhang J, Wang X, Tu S, Deng X, et al. Impact of Dronedarone on Early Recurrence After Catheter Ablation in Patients With Nonparoxysmal Atrial Fibrillation. Cardiovascular Therapeutics. 2025. doi:10.1155/cdr/2585953

BibTeX
@article{Long2025,
  author = {Long, Xianglin and Lv, Han and Zhang, Jingliang and Wang, Xiaoyan and Tu, Shan and Deng, Xu and Zeng, Lixiong and Luo, Wenzhi and Ye, Fei and Zhang, Zhihui},
  title = {Impact of Dronedarone on Early Recurrence After Catheter Ablation in Patients With Nonparoxysmal Atrial Fibrillation},
  journal = {Cardiovascular Therapeutics},
  year = {2025},
  doi = {10.1155/cdr/2585953}
}
Kostenlos starten →